The first batch of Sinopharm Covid-19 vaccine would be available at some hospitals and privates clinics in Singapore from Monday (August 30, 2021). The registration for the same would begin from Saturday and administration of the vaccine would start from Monday.
Interested people may book an appointment at healthcare firm Clearbridge Health's Medic Surgical and Laser Clinic at Tanjong Pagar Plaza. The price of the vaccine has been capped at $98, including all goods and service taxes (GST).
Vaccine appointments at IHH Healthcare, Singapore would begin from Monday. IHH Healthcare would offer the Sinopharm vaccine at Gleneagles Hospital, Mount Elizabeth Hospital and Shenton Medical Group clinics in One Raffles Quay and Duxton. IHH Healthcare would administer the doses at $99, including GST.
Also Read: 'Era of citizen convenience', book Covid vaccine slot via WhatsApp; Check how
According to the website, to request an appointment, people can email cpac@parkwaypantai.com and reply with the following details:
- Your name
- NRIC/FIN
- Date of birth
- Contact number
- Email address
- Preferred location and appointment slot
Vaccine administration at Gleneagles Hospital and the Shenton Medical Group clinics would be available from Wednesday (September 1).
Mount Elizabeth Hospital will begin administering it from September 7, 2021.
Also Read: Five must-know facts about Zydus Cadila’s covid Vaccine for children above 12
Clearbridge Medical Group said that it has received the first batch of the covid-19 vaccine on Saturday directly from the manufacturers and the administration of the vaccine would begin from Monday.
The Sinopharm vaccine is administered in two doses, the second dose is given after three-four weeks of the first dose. People aged 18 or above are eligible for the administration of the Sinopharm Covid-19 vaccine.
The Sinopharm vaccine is the fourth vaccine that has got permission to be used in Singapore. It is imported under the Special Access Route, along with the Sinovac vaccine.
Health Minister Ong Ye Kung announced earlier this month that those who have taken the Sinovac, Sinopharm, Johnson & Johnson, Covishield or AstraZeneca Covid-19 vaccines would be eligible for vaccination-differentiated safe management measures.